IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
18 hedge funds and large institutions have $5.24M invested in Interpace Biosciences, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$231K | |
| 2 | +$199K | |
| 3 | +$15.8K | |
| 4 |
VF
Virtu Financial
New York
|
+$15.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.7K |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$320K | |
| 3 | -$26K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.18K |